Medicure Stock Odds of Future Pink Sheet Price Finishing Under 0.01

MCUJF Stock  USD 0.58  0.12  17.14%   
Medicure's future price is the expected price of Medicure instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Medicure performance during a given time horizon utilizing its historical volatility. Check out Medicure Backtesting, Medicure Valuation, Medicure Correlation, Medicure Hype Analysis, Medicure Volatility, Medicure History as well as Medicure Performance.
  
Please specify Medicure's target price for which you would like Medicure odds to be computed.

Medicure Target Price Odds to finish below 0.01

The tendency of Medicure Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 0.01  or more in 90 days
 0.58 90 days 0.01 
near 1
Based on a normal probability distribution, the odds of Medicure to drop to $ 0.01  or more in 90 days from now is near 1 (This Medicure probability density function shows the probability of Medicure Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Medicure price to stay between $ 0.01  and its current price of $0.58 at the end of the 90-day period is under 4.
Assuming the 90 days horizon Medicure has a beta of -0.0354. This indicates as returns on the benchmark increase, returns on holding Medicure are expected to decrease at a much lower rate. During a bear market, however, Medicure is likely to outperform the market. Additionally Medicure has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Medicure Price Density   
       Price  

Predictive Modules for Medicure

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Medicure. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.030.584.35
Details
Intrinsic
Valuation
LowRealHigh
0.030.534.30
Details
Naive
Forecast
LowNextHigh
0.010.504.27
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.580.580.58
Details

Medicure Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Medicure is not an exception. The market had few large corrections towards the Medicure's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Medicure, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Medicure within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.25
β
Beta against Dow Jones-0.04
σ
Overall volatility
0.07
Ir
Information ratio -0.1

Medicure Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Medicure for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Medicure can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Medicure generated a negative expected return over the last 90 days
Medicure has some characteristics of a very speculative penny stock
Medicure has high historical volatility and very poor performance
The company reported the revenue of 21.74 M. Net Loss for the year was (727 K) with profit before overhead, payroll, taxes, and interest of 12.71 M.
About 27.0% of the company outstanding shares are owned by corporate insiders
Latest headline from investing.com: Forte Biosciences CFO acquires 124,997 in company stock

Medicure Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Medicure Pink Sheet often depends not only on the future outlook of the current and potential Medicure's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Medicure's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding10.3 M
Cash And Short Term Investments3.7 M

Medicure Technical Analysis

Medicure's future price can be derived by breaking down and analyzing its technical indicators over time. Medicure Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Medicure. In general, you should focus on analyzing Medicure Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Medicure Predictive Forecast Models

Medicure's time-series forecasting models is one of many Medicure's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Medicure's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Medicure

Checking the ongoing alerts about Medicure for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Medicure help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Medicure generated a negative expected return over the last 90 days
Medicure has some characteristics of a very speculative penny stock
Medicure has high historical volatility and very poor performance
The company reported the revenue of 21.74 M. Net Loss for the year was (727 K) with profit before overhead, payroll, taxes, and interest of 12.71 M.
About 27.0% of the company outstanding shares are owned by corporate insiders
Latest headline from investing.com: Forte Biosciences CFO acquires 124,997 in company stock

Other Information on Investing in Medicure Pink Sheet

Medicure financial ratios help investors to determine whether Medicure Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicure with respect to the benefits of owning Medicure security.